Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

by Naomi P. Visanji, Anthony E. Lang, Gabor G. Kovacs
Published 2019-09-01

Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease

by Naomi P. Visanji, Susan H. Fox, Tom Johnston, Gabriela Reyes, Mark J. Millan, Jonathan M. Brotchie
Published 2009-08-01

Deposits of disease-associated alpha-synuclein may be present in the dura mater in Lewy body disorders: implications for potential inadvertent transmission by surgery

by Ellen Gelpi, Naomi P. Visanji, Selma Hönigschnabl, Angelika Reiner, Peter Fischer, Anthony Lang, Herbert Budka, Gabor G. Kovacs
Published 2020-02-01

Retraction Note to: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors

by Sabine Wislet-Gendebien, Naomi P. Visanji, Shawn N. Whitehead, Diana Marsilio, Weimin Hou, Daniel Figeys, Paul E. Fraser, Steffany A. L. Bennett, Anurag Tandon
Published 2021-06-01

Deep brain stimulation of the subthalamic nucleus preferentially alters the translational profile of striatopallidal neurons in an animal model of Parkinson’s disease

by Iman eKamali Sarvestani, Iman eKamali Sarvestani, Naomi P Visanji, Meaghan C Creed, Zahra eShams Shoaei, José eNobrega, Clement eHamani, Clement eHamani, Lili-Naz eHazrati
Published 2015-06-01